NVO (NOVO NORDISK)LLY (ELI LILLY)
Novo's Wegovy Pill Still Leads the GLP-1 Pill Market as Lilly's Foundayo Launches
Novo's Wegovy Pill Still Leads the GLP-1 Pill Market as Lilly's Foundayo Launches
By Staff·June 9, 2026·二〇二六年六月九日·2 min read
Related Dispatches
相關報導- 01
Tachyon9 Signs Indian Offtake Deal That Bets North Dakota Gas Can Win the AI Power Race
A data-center deal signed in Coral Gables this week says as much about the global race for AI compute as it does about either…
June 22, 2026 · 3 min
- 02
What Is a Derivative? The Contracts Behind Modern Finance
If you have ever heard a coworker brag about buying call options on Nvidia, or seen an airline lock in cheap jet fuel before…
June 16, 2026 · 2 min
- 03
India's Yotta Crosses the Pacific: Why Nidar's Florida MOU Is a Cross-Border AI-Power Bet
Tachyon9 Corporation said it has signed a binding 15-year Memorandum of Understanding with Nidar Infrastructure Limited, the…
June 15, 2026 · 4 min
Elsewhere on the Desk
All Dispatches →Markets市場
Orlando attendance softens in June, clouding Comcast theme parks outlook
July 23, 2026 · 2 min
Markets市場American Airlines cuts 2026 earnings outlook as fuel costs climb
July 23, 2026 · 2 min
Markets市場Alphabet's $80 billion SpaceX stake sits under lockup as private-market holdings face new scrutiny
July 23, 2026 · 2 min
Markets市場Rivian shares drop more than 10% as 75-million-share offering follows sharp two-week run
July 23, 2026 · 2 min